Published 20 hours ago • loading... • Updated 20 hours ago

Myosin Therapeutics Invited to Present at Two South Florida Life Sciences Conferences

On March 10, Myosin Therapeutics announced invitations to the Investival Showcase on March 10 and BioFlorida's Cornerstone Session on March 24, the company said.
After presenting at BioCom California and the BIO Investor Forum, Myosin was invited to showcase at two South Florida events, citing progress in its clinical-stage oncology pipeline.
The investigational therapy MT-125 is in Phase 1/2 testing and holds Orphan Drug and Fast Track designations, designed to disrupt cancer cell mechanics.
The CEO will use the showcases to meet capital providers and potential strategic partners, leading discussions with investors, pharmaceutical companies, and regional life sciences stakeholders during the events.
Expansion into other aggressive cancers positions Myosin within broader oncology development efforts, as Dr. Miller said the approach advances a therapy causing a 'selective failure' of cancer cell mechanics.

Insights by Ground AI

29 Articles

The Courier-Tribune

+28 Reposted by 28 other sources

Center

Myosin Therapeutics Invited to Present at Two South Florida Life Sciences Conferences

JUPITER, Fla., March 9, 2026 /PRNewswire/ -- Myosin Therapeutics today announced it has been invited to present at two upcoming South Florida life sciences events highlighting emerging biotechnology innovation and regional industry growth. On March 10, the company will participate…

20 hours ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year